AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,504,613 | +157.0% | 53,129 | +108.5% | 0.07% | +213.0% |
| Q1 2023 | $585,390 | +50.5% | 25,485 | +45.4% | 0.02% | +91.7% |
| Q2 2022 | $389,000 | +10.5% | 17,533 | +45.0% | 0.01% | -7.7% |
| Q1 2022 | $352,000 | -83.7% | 12,092 | -81.6% | 0.01% | -84.5% |
| Q4 2021 | $2,164,000 | -45.2% | 65,824 | -13.9% | 0.08% | -31.7% |
| Q1 2021 | $3,946,000 | +119.3% | 76,419 | +84.1% | 0.12% | +105.0% |
| Q4 2020 | $1,799,000 | +55.9% | 41,512 | +25.9% | 0.06% | -60.8% |
| Q3 2020 | $1,154,000 | – | 32,967 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |